# Immune Response BioPharma, Inc. — Form D/A

Immune Response BioPharma, Inc. of NEW YORK, NY, a company, filed a Form D amendment with the SEC on 2011-08-02. The offering totals $1.0B. Industry: Pharmaceuticals.

## Offering

- Filed: 2011-08-02
- Form: D/A
- Accession: 0001524679-11-000003
- Industry: Pharmaceuticals
- Exemptions: 04, 05, 04.1, 06, 04.2, 46, 04.3
- Total offering: $1.0B
- Remaining: $1.0B
- Minimum investment: $10K
- Security types: equity, debt
- Revenue range: No Revenues
- SEC file number: 021-163802

## Issuer

- Name: Immune Response BioPharma, Inc.
- CIK: 0001524679
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2011
- Address: 244 5TH AVENUE SUITE 1727, NEW YORK, NY, 10001
- Phone: 9172757931

## Officers, directors & promoters (1)

| Name | Role | Location |
| --- | --- | --- |
| David Robert Buswell | Executive Officer | Atlantic City, NJ |

## Other filings by this issuer (3)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2012-08-14](https://search.stillhousedata.com/formd/0001524679-12-000001) | D | $1.0B | — |
| [2011-08-02](https://search.stillhousedata.com/formd/0001524679-11-000002) | D | $1.0B | — |
| [2011-07-01](https://search.stillhousedata.com/formd/0001524679-11-000001) | D | $10.0M | — |

## More

- [CIK 1524679 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1524679&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001524679-11-000003.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.